Background-Genetic studies of cardiomyopathy and heart failure have limited throughput in mammalian models. Adult zebrafish have been recently pursued as a vertebrate model with higher throughput, but genetic conservation must be tested. Methods and Results-We conducted transcriptome analysis of zebrafish heart and searched for fish homologues of 51 known human dilated cardiomyopathy-associated genes. We also identified genes with high cardiac expression and genes with differential expression between embryonic and adult stages. Among tested genes, 30 had a single zebrafish orthologue, 14 had 2 homologues, and 5 had ≥3 homologues. By analyzing the expression data on the basis of cardiac abundance and enrichment hypotheses, we identified a single zebrafish gene for 14 of 19 multiple-homologue genes and 2 zebrafish homologues of high priority for ACTC1. Of note, our data suggested vmhc and vmhcl as functional zebrafish orthologues for human genes MYH6 and MYH7, respectively, which are established molecular markers for cardiac remodeling. Conclusions-Most known genes for human dilated cardiomyopathy have a corresponding zebrafish orthologue, which supports the use of zebrafish as a conserved vertebrate model. Definition of the cardiac transcriptome and fetal gene program will facilitate systems biology studies of dilated cardiomyopathy in zebrafish. (Circ Cardiovasc Genet. 2015;8:261-269.
T he identification of DMD (Duchenne muscular dystrophy) and ACTC1 (actin, alpha cardiac muscle 1) as the first causative genes for X-linked and autosomal-dominant dilated cardiomyopathy (DCM), respectively, opened the door for genetic studies of idiopathic heart failure. 1, 2 Although mutations in dozens of genes have been linked to DCM, 3 current genetic testing panels only have a 37% yield. 4 Therefore, the discovery of novel DCM genes or modifier genes for cardiomyopathy remains a major challenge. The rapid advance of genomic technologies, such as genome-wide linkage analysis, genome-wide association studies, whole-exome sequencing, and RNA sequencing (RNA-seq), has accelerated the discovery process. Several candidate genes typically result from such studies, which necessitates further experimental validation and mechanistic studies. Mouse is the most prevalent animal model. However, the high cost of mouse and other mammalian models imposes substantial restrictions. More affordable alternative vertebrate animal models with higher throughput are desirable.
Clinical Perspective on p 269
Zebrafish (Danio rerio) is a nonmammalian vertebrate model widely used to study developmental genetics and functional genomics. Genetic resources and tools with higher throughput create novel research opportunities for cardiomyopathy, including (1) the capacity to conduct large-scale mutagenesis screening using as mutagens N-ethyl-N-nitrosourea, 5 virus, 6 or transposons 7 ; (2) the complete sequence of the zebrafish genome; (3) the development of targeting inducedlocal lesions in genomes technology, which has been used to generate mutations for about half the genome (http://www. sanger.ac.uk/Projects/D_rerio/zmp/) 8 ; (4) morpholino technology, which can be used to quickly knock down genes during embryogenesis 9 ; and (5) genome-editing technology using transcription activator-like effector nucleases or clustered regularly interspaced short palindromic repeats, which can be used to generate targeted gene knockouts, conditional gene knockouts, large-fragment genome deletions, or gene knockins. 10 The positional cloning of titin and tnnt2 as causative genes for pickwick and silent heart, 2 embryonic lethal mutants identified from an N-ethyl-N-nitrosourea-based mutagenesis screen, initiated efforts to apply zebrafish as a model for studying human cardiomyopathy. 11, 12 Additional studies in zebrafish embryos have been conducted to annotate functions of known cardiomyopathy genes, such as actn2, myh, and myl, [13] [14] [15] to discover new cardiomyopathy genes, such as nexilin, lama4, and ilk, [16] [17] [18] to mimic the cardiac remodeling process, 19 and to screen compounds of potential therapeutic value. 20 However, fish embryos cannot be used to recapitulate the full spectrum of human cardiomyopathy, a disease progressing from an initial compensated phase to a later decompensated stage. Accordingly, adult zebrafish models for cardiomyopathy have been recently pursued. Cardiomyopathylike phenotypes have been reported in adult fish stressed by either chronic anemia or doxorubicin. 21, 22 However, there are still concerns about the conservation of zebrafish cardiomyopathy models, and gene-based adult models have yet to be generated.
Toward the goal of establishing adult zebrafish as a vertebrate model for large-scale genetic studies of cardiomyopathy, we conducted transcriptome studies of zebrafish heart and assessed the conservation of the zebrafish model by seeking zebrafish orthologues of human DCM-associated genes. 3, 23 In mammals, many fetal genes, which are quiescent in the adult stages but can be reactivated during heart failure, have been used as molecular markers for the pathogenesis of cardiomyopathy. 24 Therefore, we also defined the cardiac transcriptome in both larva and adult zebrafish and conducted differential expression analysis between larva and adult heart.
Materials and Methods

Fish Husbandry
Wild-type WIK fish were used for this study. This study was approved by the Mayo Clinic Institutional Animal Care and Use Committee.
RNA Preparation
Fifty hearts from zebrafish larvae 4 days post fertilization were dissected and pooled. This stage was selected because of the maturity of heart structures and the accessibility of the hearts for surgical removal. Five hearts consisting of both atrium and ventricle were dissected and pooled from 6-month-old WIK fish. Muscle samples consisting of both fast-twitch and slow-twitch fibers were dissected from an adult fish. Tissues were homogenized using a mortar and pestle (Fisher Scientific), and total RNA was extracted using TRIzol (Sigma) according to the manufacturer's instructions. RNA quality was assessed using a 2100 Bioanalyzer Instrument (Agilent Technologies) in the Mayo DNA sequencing core facility.
Preparation of Libraries
RNA libraries were prepared according to the manufacturer's instructions for the TruSeq RNA Sample Prep Kit version 2 (Illumina). The liquid-handling EpMotion 5075 robot (Eppendorf) was used for TruSeq library construction. All AMPure bead (Beckman Coulter) clean up, mRNA isolation, end repair, and A-tailing reactions were completed on the 5075 robot. Reverse transcription and adaptor ligation steps were performed manually. The adapter-modified DNA fragments were then enriched by 12 cycles of polymerase chain reaction (PCR) using primers included in the Illumina Sample Prep Kit. Concentration and size distribution of the libraries were determined on an Agilent Bioanalyzer DNA 1000 chip. Sample concentration was confirmed using a Qubit fluorometer (Invitrogen). Libraries were loaded onto paired-end flow cells at concentrations of 8 to 10 pmol/L to generate cluster densities of 700 000/mm 2 
Mapping of Sequence Reads
The generated FASTQ sequence reads from an Illumina HiSeq instrument were aligned to the latest available zebrafish genome assembly (Zv9) by TopHat. 25 At most, 2 mismatches were allowed for the first 32 bases in each alignment. Reads with >2 mismatches or that mapped to multiple genomic locations (an alignment score, <4) were deleted. In all, 32 677 genes were annotated in Ensembl Zv9. The raw read counts for genes were generated by HTSeq (http://www-huber. embl.de/users/anders/HTSeq/doc/overview.html) for further downstream analyses.
Differential Gene Expression Analysis
For analysis of differential gene expression, we eliminated genes without any reads across all samples. Statistical testing was done using the R package DESeq. 26 Because the primary goal of our analysis was to explore the underlying cause of differentially expressed genes between different tissues, an adjusted P value/false discovery rate (to adjust for multiple testing using the Benjamin-Hochberg method) cutoff of 0.01 was used to select genes that are significantly changed. In addition, we used the following 2 criteria to identify genes differentially expressed in embryo and adult: (1) the number of reads per kilobase per million reads (RPKM) for the gene was ≥0.3 in either the embryonic transcriptome or the adult transcriptome and (2) the change in the expression level was ≥2 fold.
Functional Annotation Bioinformatics Microarray Analysis (DAVID; http://david.abcc.ncifcrf.gov/home.jsp) was used to assign genes into pathway categories. 27
Quantitative Reverse Transcriptase PCR
The Superscript III First-Strand Synthesis System (Invitrogen) was used to generate cDNA from 500 ng of RNA. Quantitative reverse transcriptase PCR (qPCR) was carried out using a Roche LightCycler 480 QPCR apparatus in 96-well QPCR plates (Roche Diagnostics Corp). The expression of the genes was normalized using the expression level of gapdh or actb2 by -∆∆Ct (cycle threshold) values. Nine RNA samples (3 each for embryonic heart, adult heart, and adult muscle) were analyzed in triplicate by qPCR. The primers are listed in Table I in the Data Supplement.
Data Analysis
We used RPKM as the normalization method to calculate gene expression in each library of each tissue. In the differential gene expression analysis, the R package DESeq was used to normalize the gene raw read counts by considering both library size and expression distribution. To overcome the overdispersion problem in RNA-seq data, a modified negative binomial distribution model was used.
Results
Definition of Cardiac Transcriptome in a Zebrafish Heart
Using the standard paired-end RNA-seq protocol, we obtained >74, 114, and 130 million reads for embryonic hearts, adult hearts, and adult muscles, respectively ( Table II in the Data Supplement). More than 75% of reads could be mapped to the Zv9 zebrafish genome. The reads were highly consistent within the 3 biological repeats for each experimental condition, as indicated by the correlation analysis ( Figure I in the Data Supplement).
Two previous transcriptome studies used RPKM cutoffs of 3 or greater 28 or 0.3 29 to delineate expression levels in the heart. Using the RPKM cutoff of 3, 5345 genes or 16% of the 32 677 genes in the zebrafish genome met the criteria in an adult zebrafish heart and 6169 genes or 19% of the genome met the criteria in the embryonic zebrafish heart. Using the RPKM cutoff of 0.3, 14 797 genes or 45% of the genome and 15 217 genes or 47% of the genome are expressed in an adult heart and an embryonic heart, respectively. Previously, it has been shown that the 200 most abundant mRNAs in the mouse heart, which account for <1% of all 25 000 mouse gene transcripts, make up ≈65% of the total cardiac mRNA pool. 30 In zebrafish, the 200 most abundant genes made up ≈66% and 61% of the total mRNA pool in the embryonic heart and the adult heart, respectively.
Using differential gene expression analysis, we identified 2795 upregulated genes that exhibit high expression in the embryonic heart but low expression in the adult heart and 3175 downregulated genes with low expression in the embryonic heart but high expression in the adult heart. Among the upregulated genes, Kyoto Encyclopedia of Genes and Genomes pathway analysis identified several genes related to cell cycle and DNA replication ( Table III in the Data Supplement; P<0.05). The downregulated pathways (P<0.05) included those involved in carbohydrate metabolism ( Table III in the Data Supplement). We also discovered decreased expression of genes in the calcium signaling pathway at 4 days post fertilization, which were activated in the adult heart (Table IV in the Data Supplement). Some of these genes were orthologues of known fetal genes involved in calcium handling, 31 including atp2a2a (orthologue of SERCA2A, -3.57-fold change), slc8a1a (orthologue of NCX1, -2.46-fold change), and slc8a2a (orthologue of NCX2, -5.62-fold change).
In mammals, the expression of some sarcomeric genes switches from fetal to adult isoforms after birth. Similarly, in zebrafish, we detected 25 genes with high expression in the larval stage that were downregulated at the adult stage (Table VA in the Data Supplement) and 17 genes with low expression during the embryonic stage that were upregulated at the adult stage ( Table VB in 
Identification of Zebrafish Homologues of 51 DCM-Associated Genes
Previous human genetic studies suggested 51 genes as causing or conferring susceptibility to inheritable DCM. 3, 23, 32 Our survey of the orthology data in the zfin data report (http://zfin. org/downloads/human_orthos.txt) and Ensembl (http://www. ensembl.org/index.html) identified zebrafish homologues for 46 of these genes. For the 5 DCM genes that did not have a clear homologue, we searched either the literature or the National Center for Biotechnology Information database for further information. Results were found for 3 of these genes. For the human gene SCN5A, scn5laa and scn5lab have been suggested as orthologues in zebrafish 33 ; these are currently named scn12aa and scn12ab, respectively, in Ensembl. Ensembl suggests that dsc2l may be the zebrafish orthologue of desmocollin 2. 34 Although 3 DSC genes exist in humans that exhibit tissuespecific expression patterns (DSC1, DSC2, and DSC3), there is only 1 dsc2l gene in zebrafish. Although no zebrafish orthologue of phospholamban was suggested from either zfin or Ensembl, a phospholamban-like gene (NM_001201561.1) was annotated in the National Institutes of Health database (http://www.ncbi. nlm.nih.gov/nuccore), which exhibits 50% protein identity to the human counterpart. Insufficient information was found for the other 2 genes. There are several candidate zebrafish homologues for FOXD4, but the closest homologue is foxd5. Because the gene is indicated as a potential orthologue with a low-confidence score in Ensembl, we consider the zebrafish orthologue of FOXD4 to remain unclear. Finally, we found no zebrafish orthologue for Cardiotrophin 1, which might encode a cytokine that only exists in mammals.
Of the 49 total zebrafish homologues for human DCM genes that we identified, 30 had a single orthologue in zebrafish. Identities of the proteins encoded by these orthologues ranged from 10.14% to 86.73% (mean, 59%; Table 1 ). The other 19 DCM genes had multiple zebrafish homologues ( 
Assessment of Cardiac Abundance of the 30 DCM Genes With a Single Orthologue
It is posited that genes with higher abundance in a particular organ must have important roles in this organ. This abundance hypothesis motivated efforts to generate a cardiac-expressed sequence tag collection, 35 to define genes with higher expression levels in the heart via RNA-seq analysis, 28 and to enrich cardiac mutant lines via an expression-based strategy. 36 Given that DCM-associated genes have been shown to have pivotal roles in cardiac diseases, we set out to test the abundance hypothesis by assessing the expression level of the 30 genes with a single zebrafish orthologue.
When RPKM ≥0.3 was used as the cutoff, 28 orthologues (93%) met the criteria in both adult and embryonic hearts; dmd and nebl did not meet the criteria (Table 1) . We then compared the expression level of the 30 DCM orthologues with those of the whole genome. The average RPKM value of the orthologues for the 30 DCM genes was significantly higher than that of the whole genome (mean, 1.0×10 0.77 versus 1.0×10 -0.33 ; P<0.001) in adult hearts ( Figure IIIA in the Data Supplement). Similarly, the average expression level of the orthologues for the 30 genes was significantly higher in the embryonic heart than in the whole genome (mean, 1.0×10 0.56 versus 1.0×10 -0.18 ; Figure IIIB in the Data Supplement).
When RPKM ≥3 was used as the cutoff, 19 of 30 genes (57%) were considered highly expressed in the adult heart and 17 of 30 genes (63%) were highly expressed in the embryonic heart. Together, our expressional analysis of 30 DCM genes supports the abundance hypothesis. Moreover, our data support that RPKM ≥0.3 is a reasonable cutoff to define the zebrafish cardiac transcriptome.
Prioritization of Zebrafish Homologues for 19 DCM-Associated Genes With Multiple Homologues
To facilitate future genetic studies of the 19 DCM-associated genes with multiple homologues, we attempted to prioritize the corresponding 59 zebrafish homologues according to their cardiac expression profile. We applied the abundance hypothesis for this prioritization process; among multiple homologues of the same DCM-causative gene, the homologue with higher abundance in the heart is given higher priority. Moreover, we applied a cardiac enrichment hypothesis in our prioritization process; among multiple homologues of the same DCM gene, the homologue exhibiting higher expression in the heart than in the muscle was given higher priority.
By applying these 2 criteria to 28 homologues for the 14 DCM genes with 2 homologues, we could prioritize 1 homologue compared with the other for 10 DCM genes *The abundance is defined as the percentage of expression level for each homologue among all homologues for the same DCM-causative gene (ie, RPKM of 1 homologue/[sum of RPKM of all homologues for the same DCM-causative gene]). The percentage of a homologue >20%, 40%, 60%, 80%, or 100% is assigned an abundance priority score of 1 (√) through 5 (√√√√√), respectively. †The score for cardiac enrichment is calculated by the ratio of RPKM in heart to that in muscle. A ratio >2-, 10-, 100-, or 1000 fold is assigned an enrichment priority score of 2 (√√) through 5 (√√√√√), respectively. We then applied the 2 criteria to analyze 31 homologues for the 5 DCM genes with ≥3 homologues ( Table 2) . Among the 3 homologues of TNNT2, only tnnt2a scored much higher than the others and thus is recommended. Compared with 3 TNNI homologues in mammals, including TnI-fast, TnI-slow, and TnI-cardiac, 37 there are 14 troponin I homologues in zebrafish, including 2 tandem duplications of tnni2a.1-4 and tnni2b1 and tnni2b12. None of them is assigned as the zebrafish TNNI3 orthologue in the zfin database, whereas some of them are recommended by Ensembl with low confidence. According to our RNA-seq data, tnni1b was the major cardiac isoform with both high abundance and cardiac-enriched expression and thus is recommended. Our data also suggested that tnni2a.3 and tnni2b.2 were the 2 major skeletal muscle isoforms. No ACTC1 orthologue is reported in the zfin database, and only acta1b is listed as an orthologue in Ensembl. Our RNA-seq data indicated that actc1a was the major actin isoform and acta1b was the minor isoform in both embryonic and adult hearts. In contrast, actc1b is a skeletal muscle-enriched isoform that accounts for 99.79% of total actin at the mRNA level in adult muscle. Therefore, both actc1a and acta1b should be considered when studying ACTC1based DCM in zebrafish. qPCR of 10 genes under each condition showed high correlation of the fold changes between the 2 methods ( Figure IIB 
Prioritization of Zebrafish Myosin Heavy Chain Homologues
Zebrafish have 9 MYH homologues. Seven homologues share >80% protein identity with MYH6 and MYH7, but myh7ba and myh7bb share 67% and 66% identities, respectively, with MYH7 (Table VI in the Data Supplement). In a 4-day postfertilization embryonic heart, myh6 (also termed amhc, atrial myosin heavy chain), vmhc (ventricle myosin heavy chain), and vmhcl (ventricle myosin heavy chain-like) represent the 3 most abundant homologues (12.13%, 31.36%, and 53.36%, respectively), whereas in an adult heart, vmhcl contributes to 88% of the total myh transcripts. According to the cardiac enrichment hypothesis, myh6 and vmhcl are highly enriched in the heart compared with muscle ( Table 2 ; Figure 1A and 1B) .
Because a previous study in larva stage indicated that myh6/amhc expresses specifically in the atrium, whereas vmhc only expresses in the ventricle, 15 we checked chamber specificity for these promising myh homologues in adult fish ( Figure 1C ). Consistent with its embryonic expression, myh6/amhc retained its atrium-restricted expression pattern and contributed to >90% of the myosin transcripts in atrium. vmhcl expressed specifically in the ventricle and contributed to >90% of the myosin transcripts in the ventricle. In contrast to its abundant expression in the embryonic ventricle, vmhc was almost undetectable (<0.5%) in either atrium or ventricle of the adult. The expression of myh7ba and myh7bb was also low (<5%) in both chambers.
In humans, both MYH7 (α-MHC) and MYH6 (β-MHC) are expressed in myocardium and cause cardiomyopathy when mutated. 38, 39 These genes are in tandem on chromosome 14, with MYH6 located 5.3 kb downstream of MYH7 ( Figure 1D) , and their expression is developmentally regulated. MYH6 is mainly expressed in the embryonic heart, whereas MYH7 becomes the predominant adult isoform. 40 Similarly, mouse genes Myh7 and Myh6 are located in tandem on chromosome 14, with myh6 located 5.3 kb downstream of myh7. Different from human gene Myh7, mouse gene Myh7 is mainly expressed in the embryonic rodent heart, whereas Myh6 becomes the predominant adult isoform. 41 In zebrafish, vmhcl and vmhc are located in tandem on chromosome 2, with vmhc ≈4.4 kb downstream of vmhcl. Similar to that in humans, vmhc mainly expresses in embryos, whereas vmhcl becomes the predominant adult isoform. To determine whether vmhcl and vmhc respond to cardiac stresses, we assessed their expression in doxorubicin-induced cardiotoxicity. 21 vhmc expression was significantly activated and peaked at 3 dpi, and vmhcl expression was decreased. The ratio of vmhc/vmhcl was increased by 25 fold compared with that in an uninjected fish heart (Figure 2A) . Consistent with fetal gene responses in mammals, we also detected gene activation for nppa and nppb, 2 established molecular markers for cardiac remodeling ( Figure 2B) , and downregulation of genes in calcium-handling pathways, including pln, ryr2b, atp2a2, and slc8a1a, after doxorubicin treatment ( Figure 2C ). Interestingly, nppa expression recovered to basal levels at 2 weeks post injection, whereas nppb remained activated until ≥3 weeks post injection.
Discussion
Transcriptome Analysis in a Zebrafish Heart
In this study, we defined the transcriptome of a zebrafish heart. Analysis of the expression of zebrafish orthologues for 30 DCM-causative genes showed that >60% of the genes are in the top 16% for expression level and 93% are in the top 45% for expression level. These data provide quantitative support to the abundance hypothesis; that is, genes with higher abundance in a particular organ have more important roles in that organ. Accordingly, the following strategy could be used to improve the efficiency of large-scale genetic studies of DCM. One could initially focus on ≈5000 genes (≈16% of the genome, identified using RPKM ≥3) as a pilot study, which is predicted to uncover about half of DCM-related genes. If successful, one could extend the study to the additional ≈10 000 genes (≈45% of the genome, identified using RPKM ≥0.3) in an effort to uncover most of the remaining DCM-related genes.
By comparing the cardiac transcriptome of a 4-day postfertilization larval fish and an adult fish, we defined the fetal gene program in a zebrafish heart. Among the ≈5000 genes we identified with differential expression, many upregulated genes and their related pathways reflect high cell proliferation in the larval stage. Our pathway analysis also uncovered activated genes in the Hedgehog and the transforming growth factor-β signaling pathways (Tables  VII and VIII in the Data Supplement) , which have been implicated in cardiogenesis. 42 Several genes related to calcium handling and muscle contraction were identified, and their mammalian orthologues have been used as molecular markers for cardiac remodeling. Interestingly, we noted downregulated genes in carbohydrate metabolism in the larval stage, which differs from mammals. 43 This discrepancy probably reflects the difference between a zebrafish heart that develops ex utero and consumes the yolk composed of lipid and triacylglycerol and a mammalian heart that develops in utero and mainly consumes glucose delivered via the circulating blood.
Transcriptome Analysis Facilitates the Prioritization of DCM-Associated Genes in Zebrafish
Of the 51 human DCM-associated genes, 19 had >1 homologue in zebrafish. Because of a genome duplication event in teleost fish, 44 ≈15% (3105/20 479) of human genes have >1 orthologue in zebrafish. We applied the cardiac abundance hypothesis to assess the expression of different homologues for each DCM-associated gene, which seems to be highly effective. The expression of actn2, cryabb, desma, scn12ab, synbe2b, and tnnt2 contributes to >99% of the transcripts within the gene family, which strongly suggests their predominant roles in the heart. We also used the cardiac enrichment hypothesis to prioritize homologues, which partially reflects the subfunctionalization of the duplicated genes. Among the 59 fish homologues, 22 are cardiac-enriched genes and 20 are muscle-enriched genes; many of them exhibit >100 fold greater expression levels ( Table IX in the Data Supplement). By combining the 2 self-evident hypotheses, our scoring system allows us to effectively prioritize homologues for DCM genes, based on a combined score of >5. Although ultimate proof requires evidence from genetic manipulation of each homologue to model DCM pathogenesis, we advise starting with the recommended homologues.
Our systematic analysis of DCM-associated genes underscores the current status of the zfin database and Ensembl. Additional new homologues for the 51 DCM genes may be identified in the future. Some genes may be improperly annotated in the current genome. For example, actc1b should be renamed to reflect its identity as a skeletal muscle actin, not a cardiac actin, whereas acta1a and acta1b should be classified as cardiac muscle actins, not skeletal muscle actins. Combining the evidence from chromosome localization and cardiac expression profiles during development and cardiac stress, our data suggest vmhcl and vmhc as zebrafish functional orthologues for MYH7 and MYH6, respectively. More experimental evidence is required, however, before they are annotated, myh7 and myh6, respectively, because no synteny was found between zebrafish and human (data not shown). Also, amhc, not the currently used myh6 in zfin, is a more proper name for this atrium-specific homologue of MYH.
Limitations
We did not observe developmental expression changes between nppa and nppb (1.84-and 1.44-fold changes between larval and adult stages, respectively), despite both genes being molecular markers for cardiomyopathy [20] [21] [22] and in DOXinduced cardiotoxicity ( Figure 2B ). This observation could be explained by dynamic expression of nppa and nppb during cardiogenesis, which peaks at day 2 and then decreases. 20 In the future, transcriptomes should be analyzed at more time points, especially during cardiogenesis. In addition, total RNA was extracted from whole hearts, which contain heterogeneous cell populations. It is plausible that genes with either cell type-specific or tissue-restrictive expression patterns are under-represented. To address this concern, specific cell types could be isolated by fluorescence-activated cell sorting, which can then be subjected to RNA-seq analysis. Alternatively, single-cell-based RNA-seq technology can be explored. 45 
Zebrafish is a Conserved Model for Studying DCM
Recently, it has been shown that 71.4% (14 623/20 479) of human protein-coding genes have ≥1 related zebrafish homologue and that 82% of human disease-associated genes have a zebrafish counterpart. 46 Here, we demonstrated that 96% of DCM-associated genes have corresponding homologues in zebrafish, supporting our central hypothesis that zebrafish is a conserved nonmammalian model suitable for studying cardiomyopathies. In fact, as a teleost fish, zebrafish is among the lowest-level vertebrate models with a chambered heart structure and conserved cellular layers, including epicardium, myocardium, and endocardium. 47 Our systematic identification and prioritization of fish homologues of DCM-associated genes will facilitate genetic studies in zebrafish, including the generation of gene-based DCM models. Besides mutants that have already been generated by targeting induced-local lesions in genomes, mutants for the remaining genes can be easily generated by using transcription activator-like effector nuclease or clustered regularly interspaced short palindromic repeat genome-editing technology. 10 It is anticipated that the efficient zebrafish model will contribute to the validation of genetic variants discovered in human patients, the elucidation of pathological pathways, and the development of novel therapeutics for DCM. Figure 2 . Transcripts of vmhc and vmhcl respond to doxorubicin. Adult zebrafish were injected with doxorubicin (20 mg/g), and gene expression in ventricle was determined using quantitative reverse transcriptase polymerase chain reaction at 1 day, 3 days, 1 week, 2 weeks, and 3 weeks after injection. The expression level was normalized to that of actb2. Shown are expression levels of vmhc and vmhcl (A), nppa and nppb (B), and pln, ryr2b, atp2a2, and slc8a1a (C). A, The ratio of vmhc to vmhcl was increased compared with that in an uninjected fish heart (green line), right scale. n=3 in each experimental group. dpi indicates days post injection; and wpi, weeks post injection.
CLINICAL PERSPECTIVE
Dilated cardiomyopathy (DCM) is a disorder with high genetic heterogeneity. More than 50 causative genes for DCM have been identified from human genetic studies. Effective diagnosis and therapeutic development thus require an efficient animal model to study DCM of different causes. Because of the advance of powerful genetic tools, zebrafish has been recently applied to study cardiomyopathy. However, it remains unclear whether this simple vertebrate animal is sophisticated enough to recapitulate different genetic types of human DCM. Heritable cardiomyopathy models have yet to be reported in this animal, despite 2 acquired models induced by anemia and doxorubicin. The overall goal of this study was to address the conservation of zebrafish as a model for studying DCM. We demonstrated that most of the known human DCM-associated genes have corresponding zebrafish homologues. By conducting a whole-genome transcriptome analysis, we defined both the cardiac transcriptome and the fetal gene program in a zebrafish heart and suggested zebrafish orthologues for MYH6 and MYH7, which are frequently used as molecular markers of cardiac remodeling. Together, our data support zebrafish as a conserved vertebrate model suitable for studying genetic cardiomyopathies. We present a list of candidate genes that can be manipulated to model different genetic types of DCM. It is anticipated that the efficient zebrafish model will contribute to many fronts in cardiomyopathy research, including the validation of genetic variants discovered in human patients, the elucidation of pathological pathways, and the development of novel therapeutics for DCM.
